Metraipolis › archive › dc_be371ea1e645

Developing immunotherapies through glycosylation reprogramming to combat solid cancers — Europe PMC PMID:42626063

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/42626063
DOI
10.3389/fimmu.2026.1824624
License (as archived)
solo-consultazione
Archived
2026-10-07T12:33:47.171Z
SHA-256 of the archived text
7d3a343bbd2aaf3def480dfdfaf267da254fa0f32493f4c2e03ab14a33e09313
Stable URL of this page
https://metraipolis.com/documento/dc_be371ea1e645

How to cite

Developing immunotherapies through glycosylation reprogramming to combat solid cancers — Europe PMC PMID:42626063 — Europe PMC (en), https://europepmc.org/article/MED/42626063 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_be371ea1e645 (Metraipolis archive dc_be371ea1e645, sha256 7d3a343bbd2aaf3def480dfdfaf267da254fa0f32493f4c2e03ab14a33e09313)
BibTeX
@misc{dcbe371ea1e645,
  title = {Developing immunotherapies through glycosylation reprogramming to combat solid cancers — Europe PMC PMID:42626063},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/42626063},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_be371ea1e645; sha256 7d3a343bbd2aaf3def480dfdfaf267da254fa0f32493f4c2e03ab14a33e09313},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42626063. Agents can read the archived copy with the MCP tool read_document.